HomeNDC LookupRxCUI directory › RxCUI 207773

Osmotic 24 HR nifedipine 60 MG Extended Release Oral Tablet [Procardia] — RxCUI 207773

RxNorm drug concept · Semantic branded drug
RxCUI 207773 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 5 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI207773
Official nameOsmotic 24 HR nifedipine 60 MG Extended Release Oral Tablet [Procardia]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asProcardia 60 MG Osmotic 24 HR Extended Release Oral Tablet; Procardia XL 60 MG 24HR Extended Release Oral Tablet
FDA products mapped2
Package NDCs mapped5
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nifedipine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Nifedipine relaxes and widens your blood vessels. If you have high blood pressure, that widening makes it easier for your heart to pump, which brings your numbers down and lowers y...
  • What exactly is nifedipine supposed to do for me?
  • It depends on your form. If you're taking the extended-release tablet, a high-fat meal can noticeably increase the amount of drug that gets into your bloodstream. That doesn't mean...
  • Does it matter if I take nifedipine with food?
📖 Read our full Nifedipine guide →

🕸️ Concept Web — How Osmotic 24 HR nifedipine 60 MG Extended Release... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Osmotic 24 HR nifedipine 60 MG Extended Release Oral Tablet [Procardia] RxCUI 207773

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nifedipine 7417
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Procardia 203423
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nifedipine Extended Release Oral Tablet 373070
    • Nifedipine Oral Product 1158688
    • Nifedipine Pill 1158689
    • Nifedipine Extended Release Oral Tablet [Procardia] 491279
    • Procardia Oral Product 1180008
    • Procardia Pill 1180009
    • Extended Release Oral Tablet 316945
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Nifedipine 60 MG [Procardia] SBDC · 491292
  • Nifedipine Extended Release Oral Tablet [Procardia] SBDF · 491279
  • Procardia Oral Product SBDG · 1180008
  • Procardia Pill SBDG · 1180009
  • Procardia BN · 203423

📦 FDA Products & Package NDCs

2 products · 5 package NDCs
5 package NDCs map to RxCUI 207773 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00069-2650-41 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK... Procardia XL Pfizer Laboratories Div Pfizer Inc 1989-09-06
00069-2650-66 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-... Procardia XL Pfizer Laboratories Div Pfizer Inc 1989-09-06
00069-2650-72 300 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-... Procardia XL Pfizer Laboratories Div Pfizer Inc 1989-09-06
00069-2660-41 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK... Procardia XL Pfizer Laboratories Div Pfizer Inc 1989-09-06
00069-2660-66 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0069-... Procardia XL Pfizer Laboratories Div Pfizer Inc 1989-09-06
Observed labelers: Pfizer Laboratories Div Pfizer Inc (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.